DYNE THERAPEUTICS INC shareholders Q3 2021

DYNE THERAPEUTICS INC's ticker is DYN and the CUSIP is 26818M108. A total of 84 filers reported holding DYNE THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.6%.

DYNE THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
MPM ASSET MANAGEMENT LLC 4,951,303$80,409,00018.64%
Vida Ventures Advisors, LLC 2,960,046$48,071,00013.77%
Logos Global Management LP 3,619,392$58,779,0004.24%
GREAT POINT PARTNERS LLC 745,000$12,099,0002.82%
Octagon Capital Advisors LP 583,649$9,478,0002.33%
COMMODORE CAPITAL LP 305,125$4,955,0001.31%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 250,000$4,060,0000.98%
Penn Mutual Asset Management, LLC 34,886$567,0000.90%
Altium Capital Management LP 166,636$2,706,0000.71%
RA Capital Management 2,805,045$45,554,0000.63%
Soleus Capital Management, L.P. 178,360$2,897,0000.45%
Vivo Capital, LLC 577,642$9,381,0000.42%
SPHERA FUNDS MANAGEMENT LTD. 225,083$3,655,0000.31%
HHLR ADVISORS, LTD. 1,000,000$16,240,0000.21%
Artal Group S.A. 525,000$8,526,0000.19%
EcoR1 Capital, LLC 215,000$3,569,0000.12%
HARVARD MANAGEMENT CO INC 107,252$1,742,0000.10%
Redmond Asset Management, LLC 12,513$203,0000.06%
Nan Fung Group Holdings Ltd 11,629$189,0000.06%
Point72 Asset Management, L.P. 827,000$13,430,0000.06%
External links

This page lists DYNE THERAPEUTICS INC's shareholders in Q3 2021. To view DYNE THERAPEUTICS INC's shareholder history, click here.